nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—malaria	0.445	1	CbGaD
Pomalidomide—PTGS2—Dapsone—malaria	0.0522	0.136	CbGbCtD
Pomalidomide—CYP3A4—Clindamycin—malaria	0.046	0.12	CbGbCtD
Pomalidomide—CYP1A2—Proguanil—malaria	0.0403	0.105	CbGbCtD
Pomalidomide—CYP1A2—Pentoxifylline—malaria	0.029	0.0753	CbGbCtD
Pomalidomide—CYP3A4—Sulfadiazine—malaria	0.0264	0.0687	CbGbCtD
Pomalidomide—CYP1A2—Quinine—malaria	0.026	0.0675	CbGbCtD
Pomalidomide—CYP1A2—Quinidine—malaria	0.0228	0.0593	CbGbCtD
Pomalidomide—ABCB1—Quinine—malaria	0.0227	0.059	CbGbCtD
Pomalidomide—CYP3A4—Artemether—malaria	0.0225	0.0584	CbGbCtD
Pomalidomide—CYP3A4—Proguanil—malaria	0.0211	0.0549	CbGbCtD
Pomalidomide—CYP3A4—Doxycycline—malaria	0.02	0.052	CbGbCtD
Pomalidomide—ABCB1—Quinidine—malaria	0.02	0.0519	CbGbCtD
Pomalidomide—CYP3A4—Quinine—malaria	0.0136	0.0354	CbGbCtD
Pomalidomide—CYP3A4—Quinidine—malaria	0.012	0.0311	CbGbCtD
Pomalidomide—CYP3A4—Dapsone—malaria	0.0103	0.0268	CbGbCtD
Pomalidomide—TNF—blood—malaria	0.00357	0.11	CbGeAlD
Pomalidomide—CRBN—saliva-secreting gland—malaria	0.0027	0.0828	CbGeAlD
Pomalidomide—CRBN—hematopoietic system—malaria	0.00257	0.079	CbGeAlD
Pomalidomide—Developmental delay—Quinidine barbiturate—malaria	0.00213	0.0234	CcSEcCtD
Pomalidomide—Congenital anomaly—Quinidine barbiturate—malaria	0.00213	0.0234	CcSEcCtD
Pomalidomide—Thalidomide—TNF—malaria	0.00201	1	CrCbGaD
Pomalidomide—CRBN—digestive system—malaria	0.00179	0.0549	CbGeAlD
Pomalidomide—CRBN—blood—malaria	0.00171	0.0523	CbGeAlD
Pomalidomide—CRBN—bone marrow—malaria	0.00165	0.0506	CbGeAlD
Pomalidomide—CYP1A2—blood plasma—malaria	0.00153	0.047	CbGeAlD
Pomalidomide—Pelvic pain—Clindamycin—malaria	0.0015	0.0165	CcSEcCtD
Pomalidomide—PTGS2—endothelium—malaria	0.00143	0.0438	CbGeAlD
Pomalidomide—Pancytopenia—Pyrimethamine—malaria	0.00141	0.0155	CcSEcCtD
Pomalidomide—CRBN—liver—malaria	0.00133	0.0409	CbGeAlD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL15—malaria	0.00128	0.0284	CbGpPWpGaD
Pomalidomide—PTGS2—blood plasma—malaria	0.00127	0.0389	CbGeAlD
Pomalidomide—CYP3A4—blood plasma—malaria	0.00111	0.034	CbGeAlD
Pomalidomide—Pancytopenia—Proguanil—malaria	0.0011	0.0121	CcSEcCtD
Pomalidomide—Sepsis—Sulfadiazine—malaria	0.00106	0.0117	CcSEcCtD
Pomalidomide—CRBN—brain—malaria	0.00106	0.0325	CbGeAlD
Pomalidomide—Hepatobiliary disease—Proguanil—malaria	0.000977	0.0107	CcSEcCtD
Pomalidomide—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.00095	0.0211	CbGpPWpGaD
Pomalidomide—Leukopenia—Pyrimethamine—malaria	0.000928	0.0102	CcSEcCtD
Pomalidomide—TNF—Vitamin B12 Metabolism—HBB—malaria	0.000902	0.02	CbGpPWpGaD
Pomalidomide—Hypocalcaemia—Quinidine barbiturate—malaria	0.000883	0.00971	CcSEcCtD
Pomalidomide—TNF—Death Receptor Signalling—FAS—malaria	0.000851	0.0189	CbGpPWpGaD
Pomalidomide—CYP1A2—hematopoietic system—malaria	0.000846	0.026	CbGeAlD
Pomalidomide—Mediastinal disorder—Proguanil—malaria	0.000836	0.00919	CcSEcCtD
Pomalidomide—Thrombocytopenia—Pyrimethamine—malaria	0.000828	0.0091	CcSEcCtD
Pomalidomide—Mental disorder—Proguanil—malaria	0.000813	0.00893	CcSEcCtD
Pomalidomide—Malnutrition—Proguanil—malaria	0.000808	0.00888	CcSEcCtD
Pomalidomide—TNF—IL27-mediated signaling events—IL12B—malaria	0.000791	0.0176	CbGpPWpGaD
Pomalidomide—ABCB1—blood plasma—malaria	0.000784	0.0241	CbGeAlD
Pomalidomide—Depressed level of consciousness—Quinidine barbiturate—malaria	0.000781	0.00858	CcSEcCtD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL12B—malaria	0.000768	0.0171	CbGpPWpGaD
Pomalidomide—Decreased appetite—Pyrimethamine—malaria	0.000735	0.00808	CcSEcCtD
Pomalidomide—TNF—Folate Metabolism—HBB—malaria	0.000734	0.0163	CbGpPWpGaD
Pomalidomide—Cough—Proguanil—malaria	0.000705	0.00775	CcSEcCtD
Pomalidomide—PTGS2—hematopoietic system—malaria	0.000701	0.0215	CbGeAlD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—CISH—malaria	0.000689	0.0153	CbGpPWpGaD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.000683	0.00751	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Sulfadiazine—malaria	0.000672	0.00739	CcSEcCtD
Pomalidomide—TNF—Cellular roles of Anthrax toxin—IL18—malaria	0.000664	0.0148	CbGpPWpGaD
Pomalidomide—Nervous system disorder—Proguanil—malaria	0.000646	0.0071	CcSEcCtD
Pomalidomide—Skin disorder—Proguanil—malaria	0.00064	0.00704	CcSEcCtD
Pomalidomide—TNF—Overview of nanoparticle effects—CRP—malaria	0.000625	0.0139	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Pyrimethamine—malaria	0.000623	0.00685	CcSEcCtD
Pomalidomide—Nasopharyngitis—Dapsone—malaria	0.000613	0.00674	CcSEcCtD
Pomalidomide—CYP3A4—hematopoietic system—malaria	0.000612	0.0188	CbGeAlD
Pomalidomide—Dry skin—Clindamycin—malaria	0.000608	0.00668	CcSEcCtD
Pomalidomide—Muscular weakness—Dapsone—malaria	0.000604	0.00664	CcSEcCtD
Pomalidomide—TNF—IL23-mediated signaling events—IL12B—malaria	0.000597	0.0133	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000593	0.0132	CbGpPWpGaD
Pomalidomide—CYP1A2—digestive system—malaria	0.000588	0.0181	CbGeAlD
Pomalidomide—Breast disorder—Quinidine—malaria	0.000588	0.00646	CcSEcCtD
Pomalidomide—Breast disorder—Quinine—malaria	0.000588	0.00646	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—HBB—malaria	0.000583	0.013	CbGpPWpGaD
Pomalidomide—TNF—IL27-mediated signaling events—IL18—malaria	0.000581	0.0129	CbGpPWpGaD
Pomalidomide—PTGS2—kidney—malaria	0.000575	0.0176	CbGeAlD
Pomalidomide—Muscular weakness—Quinine—malaria	0.000574	0.0063	CcSEcCtD
Pomalidomide—Muscular weakness—Quinidine—malaria	0.000574	0.0063	CcSEcCtD
Pomalidomide—Decreased appetite—Proguanil—malaria	0.000573	0.0063	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Proguanil—malaria	0.000569	0.00625	CcSEcCtD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL10—malaria	0.000561	0.0125	CbGpPWpGaD
Pomalidomide—CYP1A2—blood—malaria	0.000561	0.0172	CbGeAlD
Pomalidomide—Chills—Sulfadiazine—malaria	0.000553	0.00607	CcSEcCtD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL4—malaria	0.000546	0.0121	CbGpPWpGaD
Pomalidomide—Vomiting—Pyrimethamine—malaria	0.000538	0.00591	CcSEcCtD
Pomalidomide—Neutropenia—Clindamycin—malaria	0.000536	0.00589	CcSEcCtD
Pomalidomide—Pancytopenia—Quinidine—malaria	0.000534	0.00587	CcSEcCtD
Pomalidomide—Pancytopenia—Quinine—malaria	0.000534	0.00587	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Clindamycin—malaria	0.000532	0.00585	CcSEcCtD
Pomalidomide—Breast disorder—Quinidine barbiturate—malaria	0.00053	0.00583	CcSEcCtD
Pomalidomide—Neutropenia—Quinidine—malaria	0.000526	0.00578	CcSEcCtD
Pomalidomide—Neutropenia—Quinine—malaria	0.000526	0.00578	CcSEcCtD
Pomalidomide—Body temperature increased—Proguanil—malaria	0.000521	0.00573	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Dapsone—malaria	0.000518	0.00569	CcSEcCtD
Pomalidomide—Muscular weakness—Quinidine barbiturate—malaria	0.000518	0.00569	CcSEcCtD
Pomalidomide—CYP3A4—kidney—malaria	0.000502	0.0154	CbGeAlD
Pomalidomide—TNF—Vitamin B12 Metabolism—SCARB1—malaria	0.000502	0.0112	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000501	0.0111	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—TIRAP—malaria	0.000497	0.011	CbGpPWpGaD
Pomalidomide—Urinary tract infection—Clindamycin—malaria	0.000497	0.00546	CcSEcCtD
Pomalidomide—Renal failure—Quinidine—malaria	0.000493	0.00541	CcSEcCtD
Pomalidomide—Renal failure—Quinine—malaria	0.000493	0.00541	CcSEcCtD
Pomalidomide—PTGS2—digestive system—malaria	0.000487	0.015	CbGeAlD
Pomalidomide—Epistaxis—Clindamycin—malaria	0.000482	0.0053	CcSEcCtD
Pomalidomide—Pancytopenia—Quinidine barbiturate—malaria	0.000482	0.00529	CcSEcCtD
Pomalidomide—Vertigo—Sulfadiazine—malaria	0.000482	0.00529	CcSEcCtD
Pomalidomide—Pancytopenia—Pentoxifylline—malaria	0.000481	0.00529	CcSEcCtD
Pomalidomide—Leukopenia—Sulfadiazine—malaria	0.00048	0.00527	CcSEcCtD
Pomalidomide—Neutropenia—Quinidine barbiturate—malaria	0.000474	0.00521	CcSEcCtD
Pomalidomide—PTGS2—blood—malaria	0.000464	0.0143	CbGeAlD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CISH—malaria	0.000461	0.0102	CbGpPWpGaD
Pomalidomide—Arthralgia—Sulfadiazine—malaria	0.000456	0.00502	CcSEcCtD
Pomalidomide—Infestation NOS—Pentoxifylline—malaria	0.000451	0.00496	CcSEcCtD
Pomalidomide—Infestation—Pentoxifylline—malaria	0.000451	0.00496	CcSEcCtD
Pomalidomide—Diarrhoea—Proguanil—malaria	0.000451	0.00496	CcSEcCtD
Pomalidomide—PTGS2—bone marrow—malaria	0.000449	0.0138	CbGeAlD
Pomalidomide—Renal failure—Quinidine barbiturate—malaria	0.000445	0.00489	CcSEcCtD
Pomalidomide—Urinary tract disorder—Quinidine—malaria	0.000444	0.00488	CcSEcCtD
Pomalidomide—Urinary tract disorder—Quinine—malaria	0.000444	0.00488	CcSEcCtD
Pomalidomide—Urethral disorder—Quinidine—malaria	0.000441	0.00485	CcSEcCtD
Pomalidomide—Urethral disorder—Quinine—malaria	0.000441	0.00485	CcSEcCtD
Pomalidomide—CYP1A2—liver—malaria	0.000438	0.0135	CbGeAlD
Pomalidomide—TNF—IL23-mediated signaling events—IL18—malaria	0.000438	0.00974	CbGpPWpGaD
Pomalidomide—ABCB1—hematopoietic system—malaria	0.000434	0.0133	CbGeAlD
Pomalidomide—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FAS—malaria	0.000429	0.00953	CbGpPWpGaD
Pomalidomide—Thrombocytopenia—Sulfadiazine—malaria	0.000428	0.00471	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Pentoxifylline—malaria	0.000427	0.00469	CcSEcCtD
Pomalidomide—CYP3A4—digestive system—malaria	0.000426	0.0131	CbGeAlD
Pomalidomide—Epistaxis—Pentoxifylline—malaria	0.000426	0.00468	CcSEcCtD
Pomalidomide—Vomiting—Proguanil—malaria	0.000419	0.00461	CcSEcCtD
Pomalidomide—Cardiac disorder—Quinine—malaria	0.000418	0.00459	CcSEcCtD
Pomalidomide—Cardiac disorder—Quinidine—malaria	0.000418	0.00459	CcSEcCtD
Pomalidomide—Rash—Proguanil—malaria	0.000416	0.00457	CcSEcCtD
Pomalidomide—Dermatitis—Proguanil—malaria	0.000415	0.00456	CcSEcCtD
Pomalidomide—Headache—Proguanil—malaria	0.000413	0.00454	CcSEcCtD
Pomalidomide—TNF—Folate Metabolism—DHFR—malaria	0.000412	0.00917	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—SCARB1—malaria	0.000408	0.00907	CbGpPWpGaD
Pomalidomide—CYP3A4—blood—malaria	0.000406	0.0125	CbGeAlD
Pomalidomide—Mediastinal disorder—Quinidine—malaria	0.000405	0.00446	CcSEcCtD
Pomalidomide—Mediastinal disorder—Quinine—malaria	0.000405	0.00446	CcSEcCtD
Pomalidomide—Chills—Quinine—malaria	0.000404	0.00444	CcSEcCtD
Pomalidomide—Chills—Quinidine—malaria	0.000404	0.00444	CcSEcCtD
Pomalidomide—Urinary tract disorder—Quinidine barbiturate—malaria	0.000401	0.00441	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000399	0.00438	CcSEcCtD
Pomalidomide—Urethral disorder—Quinidine barbiturate—malaria	0.000398	0.00437	CcSEcCtD
Pomalidomide—Insomnia—Sulfadiazine—malaria	0.000396	0.00435	CcSEcCtD
Pomalidomide—Mental disorder—Quinine—malaria	0.000394	0.00433	CcSEcCtD
Pomalidomide—Mental disorder—Quinidine—malaria	0.000394	0.00433	CcSEcCtD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—TLR9—malaria	0.000393	0.00873	CbGpPWpGaD
Pomalidomide—Malnutrition—Quinine—malaria	0.000392	0.0043	CcSEcCtD
Pomalidomide—Malnutrition—Quinidine—malaria	0.000392	0.0043	CcSEcCtD
Pomalidomide—Nausea—Proguanil—malaria	0.000392	0.0043	CcSEcCtD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—TIRAP—malaria	0.000388	0.00862	CbGpPWpGaD
Pomalidomide—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.000387	0.0086	CbGpPWpGaD
Pomalidomide—Back pain—Clindamycin—malaria	0.000386	0.00424	CcSEcCtD
Pomalidomide—Muscle spasms—Clindamycin—malaria	0.000384	0.00422	CcSEcCtD
Pomalidomide—Decreased appetite—Sulfadiazine—malaria	0.00038	0.00418	CcSEcCtD
Pomalidomide—TNF—amb2 Integrin signaling—ICAM1—malaria	0.000379	0.00842	CbGpPWpGaD
Pomalidomide—Gastrointestinal disorder—Sulfadiazine—malaria	0.000378	0.00415	CcSEcCtD
Pomalidomide—Cardiac disorder—Quinidine barbiturate—malaria	0.000377	0.00414	CcSEcCtD
Pomalidomide—Vertigo—Dapsone—malaria	0.000371	0.00408	CcSEcCtD
Pomalidomide—PTGS2—S1P1 pathway—KDR—malaria	0.000371	0.00824	CbGpPWpGaD
Pomalidomide—Anaemia—Clindamycin—malaria	0.000369	0.00406	CcSEcCtD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000367	0.00816	CbGpPWpGaD
Pomalidomide—Tremor—Quinidine—malaria	0.000367	0.00403	CcSEcCtD
Pomalidomide—Tremor—Quinine—malaria	0.000367	0.00403	CcSEcCtD
Pomalidomide—Mediastinal disorder—Quinidine barbiturate—malaria	0.000366	0.00402	CcSEcCtD
Pomalidomide—Chills—Quinidine barbiturate—malaria	0.000364	0.004	CcSEcCtD
Pomalidomide—PTGS2—liver—malaria	0.000363	0.0111	CbGeAlD
Pomalidomide—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.00036	0.00801	CbGpPWpGaD
Pomalidomide—Cough—Dapsone—malaria	0.00036	0.00396	CcSEcCtD
Pomalidomide—Vertigo—Clindamycin—malaria	0.000359	0.00394	CcSEcCtD
Pomalidomide—Leukopenia—Clindamycin—malaria	0.000357	0.00393	CcSEcCtD
Pomalidomide—Mental disorder—Quinidine barbiturate—malaria	0.000356	0.00391	CcSEcCtD
Pomalidomide—ABCB1—kidney—malaria	0.000355	0.0109	CbGeAlD
Pomalidomide—Malnutrition—Quinidine barbiturate—malaria	0.000353	0.00388	CcSEcCtD
Pomalidomide—TNF—FAS pathway and Stress induction of HSP regulation—FAS—malaria	0.000353	0.00786	CbGpPWpGaD
Pomalidomide—Vertigo—Quinidine—malaria	0.000352	0.00387	CcSEcCtD
Pomalidomide—Vertigo—Quinine—malaria	0.000352	0.00387	CcSEcCtD
Pomalidomide—Leukopenia—Quinine—malaria	0.000351	0.00385	CcSEcCtD
Pomalidomide—Leukopenia—Quinidine—malaria	0.000351	0.00385	CcSEcCtD
Pomalidomide—TNF—Cellular roles of Anthrax toxin—IL1B—malaria	0.000347	0.00771	CbGpPWpGaD
Pomalidomide—Body temperature increased—Sulfadiazine—malaria	0.000346	0.0038	CcSEcCtD
Pomalidomide—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.000343	0.00763	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.000343	0.00762	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor—CD36—malaria	0.000342	0.0076	CbGpPWpGaD
Pomalidomide—Back pain—Pentoxifylline—malaria	0.000341	0.00375	CcSEcCtD
Pomalidomide—TNF—IL27-mediated signaling events—IFNG—malaria	0.00034	0.00756	CbGpPWpGaD
Pomalidomide—Muscle spasms—Pentoxifylline—malaria	0.000339	0.00373	CcSEcCtD
Pomalidomide—TNF—IL23-mediated signaling events—NOS2—malaria	0.000335	0.00744	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000334	0.00742	CbGpPWpGaD
Pomalidomide—Tremor—Quinidine barbiturate—malaria	0.000331	0.00364	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000331	0.00364	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000331	0.00364	CcSEcCtD
Pomalidomide—Tremor—Pentoxifylline—malaria	0.000331	0.00363	CcSEcCtD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IFNG—malaria	0.00033	0.00734	CbGpPWpGaD
Pomalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.000328	0.00729	CbGpPWpGaD
Pomalidomide—Anaemia—Pentoxifylline—malaria	0.000326	0.00358	CcSEcCtD
Pomalidomide—TNF—Allograft Rejection—IL12B—malaria	0.000325	0.00723	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—SCARB1—malaria	0.000324	0.00721	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Sulfadiazine—malaria	0.000322	0.00354	CcSEcCtD
Pomalidomide—Confusional state—Quinidine—malaria	0.000322	0.00354	CcSEcCtD
Pomalidomide—Confusional state—Quinine—malaria	0.000322	0.00354	CcSEcCtD
Pomalidomide—Thrombocytopenia—Clindamycin—malaria	0.000319	0.00351	CcSEcCtD
Pomalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.000319	0.00709	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—CD4—malaria	0.000319	0.00709	CbGpPWpGaD
Pomalidomide—Vertigo—Quinidine barbiturate—malaria	0.000318	0.00349	CcSEcCtD
Pomalidomide—CYP3A4—liver—malaria	0.000317	0.00974	CbGeAlD
Pomalidomide—Leukopenia—Quinidine barbiturate—malaria	0.000316	0.00348	CcSEcCtD
Pomalidomide—Leukopenia—Pentoxifylline—malaria	0.000316	0.00347	CcSEcCtD
Pomalidomide—Nervous system disorder—Quinine—malaria	0.000313	0.00345	CcSEcCtD
Pomalidomide—Nervous system disorder—Quinidine—malaria	0.000313	0.00345	CcSEcCtD
Pomalidomide—Thrombocytopenia—Quinine—malaria	0.000313	0.00344	CcSEcCtD
Pomalidomide—Thrombocytopenia—Quinidine—malaria	0.000313	0.00344	CcSEcCtD
Pomalidomide—Skin disorder—Quinidine—malaria	0.00031	0.00341	CcSEcCtD
Pomalidomide—Skin disorder—Quinine—malaria	0.00031	0.00341	CcSEcCtD
Pomalidomide—Pruritus—Sulfadiazine—malaria	0.00031	0.0034	CcSEcCtD
Pomalidomide—Hyperhidrosis—Quinine—malaria	0.000309	0.0034	CcSEcCtD
Pomalidomide—Hyperhidrosis—Quinidine—malaria	0.000309	0.0034	CcSEcCtD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—TLR9—malaria	0.000306	0.00681	CbGpPWpGaD
Pomalidomide—Insomnia—Dapsone—malaria	0.000305	0.00335	CcSEcCtD
Pomalidomide—TNF—IL27-mediated signaling events—IL1B—malaria	0.000303	0.00675	CbGpPWpGaD
Pomalidomide—TNF—IL27-mediated signaling events—IL2—malaria	0.000302	0.00672	CbGpPWpGaD
Pomalidomide—ABCB1—digestive system—malaria	0.000302	0.00925	CbGeAlD
Pomalidomide—Arthralgia—Quinidine barbiturate—malaria	0.000301	0.00331	CcSEcCtD
Pomalidomide—Anxiety—Quinidine barbiturate—malaria	0.0003	0.0033	CcSEcCtD
Pomalidomide—Diarrhoea—Sulfadiazine—malaria	0.000299	0.00329	CcSEcCtD
Pomalidomide—Anxiety—Pentoxifylline—malaria	0.000299	0.00329	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000299	0.00328	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000298	0.00328	CcSEcCtD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL1B—malaria	0.000294	0.00655	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL2—malaria	0.000293	0.00652	CbGpPWpGaD
Pomalidomide—Musculoskeletal discomfort—Quinidine—malaria	0.000291	0.0032	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Quinine—malaria	0.000291	0.0032	CcSEcCtD
Pomalidomide—Confusional state—Quinidine barbiturate—malaria	0.000291	0.0032	CcSEcCtD
Pomalidomide—Dyspnoea—Clindamycin—malaria	0.00029	0.00319	CcSEcCtD
Pomalidomide—Confusional state—Pentoxifylline—malaria	0.00029	0.00319	CcSEcCtD
Pomalidomide—PTGS2—brain—malaria	0.000288	0.00884	CbGeAlD
Pomalidomide—ABCB1—blood—malaria	0.000287	0.00882	CbGeAlD
Pomalidomide—Infection—Pentoxifylline—malaria	0.000286	0.00314	CcSEcCtD
Pomalidomide—Dyspnoea—Quinine—malaria	0.000285	0.00313	CcSEcCtD
Pomalidomide—Dyspnoea—Quinidine—malaria	0.000285	0.00313	CcSEcCtD
Pomalidomide—TNF—Vitamin B12 Metabolism—CRP—malaria	0.000284	0.00631	CbGpPWpGaD
Pomalidomide—Nervous system disorder—Quinidine barbiturate—malaria	0.000283	0.00311	CcSEcCtD
Pomalidomide—Thrombocytopenia—Quinidine barbiturate—malaria	0.000282	0.0031	CcSEcCtD
Pomalidomide—Thrombocytopenia—Pentoxifylline—malaria	0.000282	0.0031	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Clindamycin—malaria	0.000281	0.00309	CcSEcCtD
Pomalidomide—Fatigue—Clindamycin—malaria	0.000281	0.00309	CcSEcCtD
Pomalidomide—Skin disorder—Quinidine barbiturate—malaria	0.00028	0.00308	CcSEcCtD
Pomalidomide—Skin disorder—Pentoxifylline—malaria	0.00028	0.00307	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—FCGR2A—malaria	0.000279	0.00621	CbGpPWpGaD
Pomalidomide—Hyperhidrosis—Quinidine barbiturate—malaria	0.000279	0.00307	CcSEcCtD
Pomalidomide—Constipation—Clindamycin—malaria	0.000279	0.00306	CcSEcCtD
Pomalidomide—Pain—Clindamycin—malaria	0.000279	0.00306	CcSEcCtD
Pomalidomide—Hyperhidrosis—Pentoxifylline—malaria	0.000278	0.00306	CcSEcCtD
Pomalidomide—Vomiting—Sulfadiazine—malaria	0.000278	0.00306	CcSEcCtD
Pomalidomide—ABCB1—bone marrow—malaria	0.000278	0.00853	CbGeAlD
Pomalidomide—Decreased appetite—Quinidine—malaria	0.000278	0.00305	CcSEcCtD
Pomalidomide—Decreased appetite—Quinine—malaria	0.000278	0.00305	CcSEcCtD
Pomalidomide—TNF—Caspase Cascade in Apoptosis—FAS—malaria	0.000277	0.00615	CbGpPWpGaD
Pomalidomide—Gastrointestinal disorder—Quinine—malaria	0.000276	0.00303	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Quinidine—malaria	0.000276	0.00303	CcSEcCtD
Pomalidomide—Rash—Sulfadiazine—malaria	0.000276	0.00303	CcSEcCtD
Pomalidomide—Dermatitis—Sulfadiazine—malaria	0.000276	0.00303	CcSEcCtD
Pomalidomide—Headache—Sulfadiazine—malaria	0.000274	0.00301	CcSEcCtD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—malaria	0.000272	0.00604	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL4—malaria	0.000267	0.00594	CbGpPWpGaD
Pomalidomide—Body temperature increased—Dapsone—malaria	0.000266	0.00293	CcSEcCtD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL12B—malaria	0.000265	0.00589	CbGpPWpGaD
Pomalidomide—Feeling abnormal—Quinine—malaria	0.000263	0.00289	CcSEcCtD
Pomalidomide—Feeling abnormal—Quinidine—malaria	0.000263	0.00289	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000263	0.00289	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000262	0.00288	CcSEcCtD
Pomalidomide—TNF—Vitamin B12 Metabolism—ICAM1—malaria	0.000261	0.0058	CbGpPWpGaD
Pomalidomide—Insomnia—Pentoxifylline—malaria	0.00026	0.00286	CcSEcCtD
Pomalidomide—Nausea—Sulfadiazine—malaria	0.00026	0.00286	CcSEcCtD
Pomalidomide—Body temperature increased—Clindamycin—malaria	0.000258	0.00283	CcSEcCtD
Pomalidomide—Dyspnoea—Quinidine barbiturate—malaria	0.000257	0.00283	CcSEcCtD
Pomalidomide—TNF—Monoamine Transport—IL1B—malaria	0.000257	0.00571	CbGpPWpGaD
Pomalidomide—Dyspnoea—Pentoxifylline—malaria	0.000257	0.00282	CcSEcCtD
Pomalidomide—TNF—IL23-mediated signaling events—IFNG—malaria	0.000257	0.0057	CbGpPWpGaD
Pomalidomide—Body temperature increased—Quinine—malaria	0.000253	0.00278	CcSEcCtD
Pomalidomide—Body temperature increased—Quinidine—malaria	0.000253	0.00278	CcSEcCtD
Pomalidomide—Decreased appetite—Quinidine barbiturate—malaria	0.000251	0.00276	CcSEcCtD
Pomalidomide—Decreased appetite—Pentoxifylline—malaria	0.00025	0.00275	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000249	0.00274	CcSEcCtD
Pomalidomide—TNF—IL23-mediated signaling events—CD4—malaria	0.000248	0.00551	CbGpPWpGaD
Pomalidomide—Constipation—Quinidine barbiturate—malaria	0.000247	0.00271	CcSEcCtD
Pomalidomide—Pain—Quinidine barbiturate—malaria	0.000247	0.00271	CcSEcCtD
Pomalidomide—Constipation—Pentoxifylline—malaria	0.000246	0.00271	CcSEcCtD
Pomalidomide—Hypersensitivity—Clindamycin—malaria	0.00024	0.00264	CcSEcCtD
Pomalidomide—TNF—Allograft Rejection—IL10—malaria	0.000238	0.00529	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CD40LG—malaria	0.000238	0.00529	CbGpPWpGaD
Pomalidomide—Feeling abnormal—Quinidine barbiturate—malaria	0.000238	0.00261	CcSEcCtD
Pomalidomide—Feeling abnormal—Pentoxifylline—malaria	0.000237	0.00261	CcSEcCtD
Pomalidomide—Hypersensitivity—Quinine—malaria	0.000235	0.00259	CcSEcCtD
Pomalidomide—Hypersensitivity—Quinidine—malaria	0.000235	0.00259	CcSEcCtD
Pomalidomide—Asthenia—Clindamycin—malaria	0.000234	0.00257	CcSEcCtD
Pomalidomide—TNF—Allograft Rejection—IL4—malaria	0.000231	0.00514	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—CRP—malaria	0.000231	0.00513	CbGpPWpGaD
Pomalidomide—Pruritus—Clindamycin—malaria	0.000231	0.00253	CcSEcCtD
Pomalidomide—Asthenia—Quinidine—malaria	0.000229	0.00252	CcSEcCtD
Pomalidomide—Asthenia—Quinine—malaria	0.000229	0.00252	CcSEcCtD
Pomalidomide—TNF—IL23-mediated signaling events—IL1B—malaria	0.000229	0.00509	CbGpPWpGaD
Pomalidomide—TNF—Overview of nanoparticle effects—IL6—malaria	0.000228	0.00508	CbGpPWpGaD
Pomalidomide—Body temperature increased—Quinidine barbiturate—malaria	0.000228	0.00251	CcSEcCtD
Pomalidomide—TNF—IL23-mediated signaling events—IL2—malaria	0.000228	0.00507	CbGpPWpGaD
Pomalidomide—Body temperature increased—Pentoxifylline—malaria	0.000228	0.0025	CcSEcCtD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—CD36—malaria	0.000226	0.00503	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—HLA-B—malaria	0.000226	0.00503	CbGpPWpGaD
Pomalidomide—Pruritus—Quinidine—malaria	0.000226	0.00249	CcSEcCtD
Pomalidomide—Pruritus—Quinine—malaria	0.000226	0.00249	CcSEcCtD
Pomalidomide—ABCB1—liver—malaria	0.000225	0.00689	CbGeAlD
Pomalidomide—Diarrhoea—Clindamycin—malaria	0.000223	0.00245	CcSEcCtD
Pomalidomide—Diarrhoea—Quinine—malaria	0.000219	0.0024	CcSEcCtD
Pomalidomide—Diarrhoea—Quinidine—malaria	0.000219	0.0024	CcSEcCtD
Pomalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000216	0.00481	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000216	0.00479	CbGpPWpGaD
Pomalidomide—Dizziness—Clindamycin—malaria	0.000215	0.00237	CcSEcCtD
Pomalidomide—Vomiting—Dapsone—malaria	0.000214	0.00235	CcSEcCtD
Pomalidomide—TNF—Allograft Rejection—FAS—malaria	0.000213	0.00474	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—FAS—malaria	0.000213	0.00474	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Quinidine barbiturate—malaria	0.000213	0.00234	CcSEcCtD
Pomalidomide—TNF—Folate Metabolism—ICAM1—malaria	0.000212	0.00472	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Pentoxifylline—malaria	0.000212	0.00233	CcSEcCtD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.000212	0.00471	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000211	0.0047	CbGpPWpGaD
Pomalidomide—Dizziness—Quinine—malaria	0.000211	0.00232	CcSEcCtD
Pomalidomide—Dizziness—Quinidine—malaria	0.000211	0.00232	CcSEcCtD
Pomalidomide—Headache—Dapsone—malaria	0.000211	0.00232	CcSEcCtD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000208	0.00462	CbGpPWpGaD
Pomalidomide—Vomiting—Clindamycin—malaria	0.000207	0.00228	CcSEcCtD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL12B—malaria	0.000207	0.0046	CbGpPWpGaD
Pomalidomide—Asthenia—Quinidine barbiturate—malaria	0.000207	0.00227	CcSEcCtD
Pomalidomide—Asthenia—Pentoxifylline—malaria	0.000207	0.00227	CcSEcCtD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000206	0.00459	CbGpPWpGaD
Pomalidomide—Rash—Clindamycin—malaria	0.000205	0.00226	CcSEcCtD
Pomalidomide—Dermatitis—Clindamycin—malaria	0.000205	0.00226	CcSEcCtD
Pomalidomide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000204	0.00455	CbGpPWpGaD
Pomalidomide—Headache—Clindamycin—malaria	0.000204	0.00224	CcSEcCtD
Pomalidomide—Pruritus—Quinidine barbiturate—malaria	0.000204	0.00224	CcSEcCtD
Pomalidomide—Pruritus—Pentoxifylline—malaria	0.000204	0.00224	CcSEcCtD
Pomalidomide—Vomiting—Quinidine—malaria	0.000203	0.00223	CcSEcCtD
Pomalidomide—Vomiting—Quinine—malaria	0.000203	0.00223	CcSEcCtD
Pomalidomide—TNF—Transcription factor regulation in adipogenesis—IL6—malaria	0.000203	0.00452	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—FAS—malaria	0.000203	0.00451	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	0.000202	0.00448	CbGpPWpGaD
Pomalidomide—Rash—Quinine—malaria	0.000202	0.00222	CcSEcCtD
Pomalidomide—Rash—Quinidine—malaria	0.000202	0.00222	CcSEcCtD
Pomalidomide—Dermatitis—Quinine—malaria	0.000201	0.00221	CcSEcCtD
Pomalidomide—Dermatitis—Quinidine—malaria	0.000201	0.00221	CcSEcCtD
Pomalidomide—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	0.000201	0.00446	CbGpPWpGaD
Pomalidomide—Headache—Quinidine—malaria	0.0002	0.0022	CcSEcCtD
Pomalidomide—Headache—Quinine—malaria	0.0002	0.0022	CcSEcCtD
Pomalidomide—Nausea—Dapsone—malaria	0.0002	0.0022	CcSEcCtD
Pomalidomide—TNF—Vitamin B12 Metabolism—IFNG—malaria	0.000198	0.00441	CbGpPWpGaD
Pomalidomide—Diarrhoea—Quinidine barbiturate—malaria	0.000197	0.00217	CcSEcCtD
Pomalidomide—Diarrhoea—Pentoxifylline—malaria	0.000197	0.00217	CcSEcCtD
Pomalidomide—CYP1A2—Arachidonic acid metabolism—HPGDS—malaria	0.000194	0.00432	CbGpPWpGaD
Pomalidomide—Nausea—Clindamycin—malaria	0.000194	0.00213	CcSEcCtD
Pomalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.000193	0.00429	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000192	0.00427	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000192	0.00426	CbGpPWpGaD
Pomalidomide—Dizziness—Quinidine barbiturate—malaria	0.000191	0.0021	CcSEcCtD
Pomalidomide—Dizziness—Pentoxifylline—malaria	0.00019	0.00209	CcSEcCtD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.00019	0.00422	CbGpPWpGaD
Pomalidomide—Nausea—Quinidine—malaria	0.00019	0.00209	CcSEcCtD
Pomalidomide—Nausea—Quinine—malaria	0.00019	0.00209	CcSEcCtD
Pomalidomide—TNF—TGF-beta Receptor Signaling—IFNG—malaria	0.00019	0.00421	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—CRP—malaria	0.000183	0.00408	CbGpPWpGaD
Pomalidomide—Vomiting—Quinidine barbiturate—malaria	0.000183	0.00202	CcSEcCtD
Pomalidomide—Vomiting—Pentoxifylline—malaria	0.000183	0.00201	CcSEcCtD
Pomalidomide—Rash—Quinidine barbiturate—malaria	0.000182	0.002	CcSEcCtD
Pomalidomide—Dermatitis—Quinidine barbiturate—malaria	0.000182	0.002	CcSEcCtD
Pomalidomide—Rash—Pentoxifylline—malaria	0.000182	0.002	CcSEcCtD
Pomalidomide—Dermatitis—Pentoxifylline—malaria	0.000181	0.00199	CcSEcCtD
Pomalidomide—Headache—Quinidine barbiturate—malaria	0.000181	0.00199	CcSEcCtD
Pomalidomide—Headache—Pentoxifylline—malaria	0.00018	0.00198	CcSEcCtD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.000179	0.00398	CbGpPWpGaD
Pomalidomide—ABCB1—brain—malaria	0.000178	0.00547	CbGeAlD
Pomalidomide—TNF—IL27-mediated signaling events—IL6—malaria	0.000178	0.00395	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—IL1B—malaria	0.000177	0.00394	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000175	0.0039	CbGpPWpGaD
Pomalidomide—PTGS2—Overview of nanoparticle effects—TNF—malaria	0.000175	0.00389	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—FCGR2A—malaria	0.000173	0.00384	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL6—malaria	0.000172	0.00383	CbGpPWpGaD
Pomalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000171	0.00381	CbGpPWpGaD
Pomalidomide—Nausea—Quinidine barbiturate—malaria	0.000171	0.00188	CcSEcCtD
Pomalidomide—Nausea—Pentoxifylline—malaria	0.000171	0.00188	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—ICAM1—malaria	0.000169	0.00375	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL4—malaria	0.000168	0.00373	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IFNG—malaria	0.000161	0.00359	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—malaria	0.000161	0.00359	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—TLR4—malaria	0.000156	0.00347	CbGpPWpGaD
Pomalidomide—TNF—amb2 Integrin signaling—IL6—malaria	0.000151	0.00335	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL1B—malaria	0.000144	0.0032	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL2—malaria	0.000144	0.00319	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—IL2—malaria	0.000144	0.00319	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—FAS—malaria	0.000143	0.00318	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL12B—malaria	0.000143	0.00317	CbGpPWpGaD
Pomalidomide—PTGS2—Overview of nanoparticle effects—IL6—malaria	0.000141	0.00314	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IFNG—malaria	0.00014	0.00311	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—TLR4—malaria	0.000139	0.00309	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL10—malaria	0.000138	0.00307	CbGpPWpGaD
Pomalidomide—TNF—IL23-mediated signaling events—IL6—malaria	0.000134	0.00298	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—ICAM1—malaria	0.000133	0.00296	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—NOS2—malaria	0.000132	0.00294	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PKLR—malaria	0.000131	0.0029	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IFNG—malaria	0.000128	0.00285	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—IL1B—malaria	0.000125	0.00277	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL1B—malaria	0.000125	0.00277	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	0.000125	0.00277	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—FAS—malaria	0.000124	0.00276	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL2—malaria	0.000124	0.00276	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase II conjugation—HPGDS—malaria	0.000124	0.00275	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—TLR4—malaria	0.000122	0.00271	CbGpPWpGaD
Pomalidomide—TNF—TWEAK Signaling Pathway—IL6—malaria	0.000121	0.00269	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	0.00012	0.00266	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000117	0.00261	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—FAS—malaria	0.000117	0.00259	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL1B—malaria	0.000114	0.00254	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—CRP—malaria	0.000113	0.00252	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.000111	0.00246	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000105	0.00234	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	0.000104	0.00232	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CD40LG—malaria	0.000104	0.00232	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL10—malaria	0.000104	0.00232	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL4—malaria	0.000104	0.00231	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—IL6—malaria	0.000104	0.0023	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL1B—malaria	0.000102	0.00226	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IFNG—malaria	0.000101	0.00226	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL4—malaria	0.000101	0.00225	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-B—malaria	9.92e-05	0.0022	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—FAS—malaria	9.35e-05	0.00208	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	9.23e-05	0.00205	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL1B—malaria	9.05e-05	0.00201	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL2—malaria	9.02e-05	0.002	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	8.95e-05	0.00199	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	8.63e-05	0.00192	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TLR4—malaria	8.6e-05	0.00191	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL6—malaria	8.43e-05	0.00187	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	8.33e-05	0.00185	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—ICAM1—malaria	8.25e-05	0.00183	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—NOS2—malaria	8.18e-05	0.00182	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	8.07e-05	0.00179	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—CD4—malaria	7.95e-05	0.00177	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL1B—malaria	7.94e-05	0.00176	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IFNG—malaria	7.93e-05	0.00176	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	7.54e-05	0.00168	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL1B—malaria	7.24e-05	0.00161	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—HPGDS—malaria	7.23e-05	0.00161	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL1B—malaria	7.08e-05	0.00157	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—IL1B—malaria	6.82e-05	0.00152	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	6.73e-05	0.0015	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	6.7e-05	0.00149	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL6—malaria	6.7e-05	0.00149	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	6.51e-05	0.00145	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—IL6—malaria	6.47e-05	0.00144	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	6.42e-05	0.00143	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IFNG—malaria	6.27e-05	0.00139	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IFNG—malaria	6.13e-05	0.00136	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—malaria	5.95e-05	0.00132	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL1B—malaria	5.6e-05	0.00124	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—HPGDS—malaria	5.58e-05	0.00124	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL2—malaria	5.58e-05	0.00124	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL1B—malaria	5.47e-05	0.00122	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL2—malaria	5.45e-05	0.00121	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL6—malaria	5.3e-05	0.00118	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—malaria	5.14e-05	0.00114	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—CD36—malaria	5.12e-05	0.00114	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	5.07e-05	0.00113	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DHODH—malaria	4.99e-05	0.00111	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.91e-05	0.00109	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—IL6—malaria	4.9e-05	0.00109	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	4.88e-05	0.00109	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	4.88e-05	0.00109	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—malaria	4.65e-05	0.00103	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	4.61e-05	0.00103	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.5e-05	0.001	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—KDR—malaria	4.42e-05	0.000983	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC4A1—malaria	4.24e-05	0.000943	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—malaria	4.24e-05	0.000942	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—malaria	4.14e-05	0.000921	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—malaria	4.06e-05	0.000903	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DECR1—malaria	3.99e-05	0.000886	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—malaria	3.97e-05	0.000882	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PKLR—malaria	3.84e-05	0.000853	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HBB—malaria	3.61e-05	0.000802	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DHODH—malaria	3.54e-05	0.000786	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—G6PD—malaria	3.42e-05	0.00076	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—malaria	3.28e-05	0.000729	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PKLR—malaria	3.21e-05	0.000715	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC4A1—malaria	3.01e-05	0.000668	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—G6PD—malaria	2.87e-05	0.000637	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	2.83e-05	0.000628	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DECR1—malaria	2.83e-05	0.000628	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DHODH—malaria	2.82e-05	0.000628	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.78e-05	0.000617	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.76e-05	0.000614	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HBB—malaria	2.56e-05	0.000568	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.55e-05	0.000567	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—DHFR—malaria	2.42e-05	0.000538	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC4A1—malaria	2.4e-05	0.000534	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PKLR—malaria	2.28e-05	0.000507	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DECR1—malaria	2.26e-05	0.000502	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HPGDS—malaria	2.19e-05	0.000486	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DHODH—malaria	2.18e-05	0.000484	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HBB—malaria	2.04e-05	0.000454	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—G6PD—malaria	2.03e-05	0.000451	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DHFR—malaria	2.03e-05	0.000451	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SCARB1—malaria	2.01e-05	0.000446	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.96e-05	0.000435	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC4A1—malaria	1.85e-05	0.000412	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PKLR—malaria	1.82e-05	0.000404	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DECR1—malaria	1.74e-05	0.000387	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—malaria	1.69e-05	0.000375	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—G6PD—malaria	1.62e-05	0.00036	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	1.6e-05	0.000356	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HBB—malaria	1.58e-05	0.00035	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HPGDS—malaria	1.55e-05	0.000344	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DHFR—malaria	1.44e-05	0.000319	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SCARB1—malaria	1.42e-05	0.000316	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PKLR—malaria	1.4e-05	0.000312	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CD36—malaria	1.26e-05	0.00028	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—G6PD—malaria	1.25e-05	0.000278	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HPGDS—malaria	1.24e-05	0.000275	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—malaria	1.24e-05	0.000275	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DHFR—malaria	1.15e-05	0.000255	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SCARB1—malaria	1.14e-05	0.000252	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HPGDS—malaria	9.54e-06	0.000212	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD4—malaria	9.15e-06	0.000203	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CD36—malaria	8.92e-06	0.000198	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DHFR—malaria	8.85e-06	0.000197	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SCARB1—malaria	8.76e-06	0.000195	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CD36—malaria	7.12e-06	0.000158	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CD36—malaria	5.5e-06	0.000122	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—malaria	4.95e-06	0.00011	CbGpPWpGaD
